ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987